The assessment of serum amylase in patients with type-II diabetes mellitus

Aafrin N. Daruwala; Akshali V. Patel; Shivani M. Kachhiya

doi:10.18203/2320-6012.ijrms20232429

Authors

Aafrin N. Daruwala Department of Biochemistry, Parul Institute of Medical Science and Research, Vadodara, Gujarat, India
Akshali V. Patel Department of Paramedical and Health Sciences, Parul Institute of Medical Science and Research, Vadodara, Gujarat, India
Shivani M. Kachhiya Department of Paramedical and Health Sciences, Parul Institute of Medical Science and Research, Vadodara, Gujarat, India

DOI:

https://doi.org/10.18203/2320-6012.ijrms20232429

Keywords:

Exocrine pancreas, Serum amylase, Type II diabetes mellitus

Abstract

Background: Diabetes mellitus (DM) is a metabolic disorder that causes excessively high blood glucose levels. As there is an interrelationship between the functional and anatomical portions of the pancreas, it may affect the exocrine portion as well. Aim of the study was to assess the level of serum amylase and random blood glucose in patients with T2DM compare and correlate it with healthy controls.

Methods: This Analytical cross sectional study was conducted in the Parul Sevashram, Hospital, Vadodara. We enrolled 100 type 2 diabetic subjects aged 40 to 60 years and 100 healthy patients to analyze their blood glucose and serum amylase levels.

Results: We found statistically sig (P <0.01) lower serum amylase levels in T2DM patients compared to healthy controls. Cases had significantly higher RBS levels than controls. The mean±SD of RBS of group-1 was 142.29±62.296 mg/dl, group-2 was 105.36±23.336 mg/dl. The mean±SD of serum amylase of group-1 was 65.949±29.5554 u/l, group-2 was 87.82±42.4896 u/l. In our study we found weak negative correlation between Plasma blood glucose and serum amylase in cases, having statistical sig P value= 0.0001 and r value was -0.384.

Conclusions: The results of our study shown that in T2DM cases, where the RBS level was higher; the serum amylase activity was significantly lower. This represented a malfunction in the pancreas endocrine-exocrine axis, as any pathological change that impacted any section of an organ would affect the surrounding area of that organ functionally.

Metrics

Metrics Loading ...

References

World Health Organization. Diabetes, 2023. Available at: https://www.who.int/news-room/fact-sheets/detail/diabetes. Accessed on 27 February 2023.

Diagnosis and classification of diabetes mellitus. American Diabetes Association. Diabetes care. 2011; 34(Supplement_1):S62-9.

World Health Organization. Diagnosis and management of type 2 diabetes. International Diabetes Federation, 2020. Available at: https://apps.who.int/iris/rest/bitstreams/1274478/retrieve. Accessed on 13 March 2023.

Bastaki S. Diabetes mellitus and its treatment. Dubai Diabet Endocrinol J. 2005;13(3):111-34.

Vishwanath HL, Shwetha N, Leelambika C. Biochemical analysis of serum amylase and lipase in patients with type 2 diabetes mellitus. Inter J Clin Bioche Res. 2019;6(1):121-5.

Ferrier D. Biochemistry. Lippincott Williams & Wilkins. 6th ed. Lippincott’s illustrated reviews; 2017.

Baynes JW, Dominiczak MH. Glucose homeostasis and fuel metabolism: diabetes mellitus. Medical Biochemistry. 4th ed. Web: Saunders Elsevier; 2014:264-90.

Mayo clinic. Type-2 diabetes. Available at: https://www.mayoclinic.org/diseases-conditions/type-2-diabetes/symptoms-causes/syc-20351193. Accessed on 25 February 2023.

Ewadh MJ, Juda TM, Ali ZA, Ewadh MM. Evaluation of amylase activity in patients with type 2 diabetes mellitus. Am J Bio Sci. 2014;2(5):171-74.

Yadav R, Bhartiya JP, Verma SK, Nandkeoliar MK. The evaluation of serum amylase in the patients of type 2 diabetes mellitus, with a possible correlation with the pancreatic functions. J clin diag res. 2013;7(7):1291.

Subedi S, Shrestha L, Gurung K, Adhikari B, Dhakal G. Status of serum amylase in type 2 diabetic patients in pokhara, nepal. J Heal Alli Sci. 2020;10(2):63-7.

Munta AK, Pyda VR, Vattam NSV, Badam LK. The association of salivary glucose, salivary amylase, serum amylase and serum glucose in diabetes and prediabetes. Res J Pharma Biolog Chem Sci. 2021;12(1).

Shilpa AM, Mahdi AA, Gupta KK, Patel ML. Treatment with gliptins and study of the variations in serum amylase and serum lipase levels in type 2 diabetes mellitus. Int J Pharma Sci Res. 2016;7(5).

Tanvi NEJ, Akhter QS, Nahar S, Sumi MN, Hosen M. Serum amylase and lipase in diabetes. J Bangladesh Soc Physiol. 2017;12(2):52-3.

Kumar A, Itagi AS, Chetan TL, Neeralagi S. Study of serum amylase levels in patients with type-2 diabetes mellitus in a tertiary care hospital. Asian J Medi Res. 2022;11(2).

Hareesh R, Harish K, Savith A. Association of serum amylase and lipase levels in newly diagnosed type 2 diabetes mellitus. Int J Advan Med. 2021;8(2):254-9.

Madole MB, Iyer CM, Madivalar MT, Wadde SK, Howale DS. Evaluation of biochemical markers serum amylase and serum lipase for the assessment of pancreatic exocrine function in diabetes mellitus. JCDR. 2016;10(11):BC01.

Snehankar K, Rumi D, Risha G, Kailash B. Serum amylase and lipase activities in newly diagnosed patients with type 2 diabetes mellitus. Inter J Advan Res. 2016;4(7):1476-83.

Jain A, Gupta V, Thimmaraju KV. Levels of serum amylase, uric acid and lipid profile in type-2 diabetes mellitus: a pilot study in rohilkhand region. Inter J Sci Res. 2016;8(6).